1 |
S. Muller, Melanin-Associated Pigmented Lesions of the Oral Mucosa: Presentation, Differential Diagnosis, and Treatment. Dermatol Ther, 2010 ; 23 : 220-9.
DOI
ScienceOn
|
2 |
2011 European Association of the Study of the Liver Hepatitis C Virus Clinical Practice Guidelines, Liver Int, 2012 ; 32 Suppl 1 : 2-8.
|
3 |
M. Willems, K. Munte, J. M. Vrolijk et al. Hyperpigmentation During Interferon-Alpha Therapy for Chronic Hepatitis C Virus Infection. Br J Dermatol, 2003 ; 149 : 390-4.
DOI
ScienceOn
|
4 |
P. C. de Moraes, C. W. Noce, L. A. Thomaz et al. Tongue Hyperpigmentation Resulting from Peginterferon Alfa and Ribavirin Combination Therapy: A Case Report. J Am Dent Assoc, 2009; 140 : 1377-9.
DOI
ScienceOn
|
5 |
D. Farshidi, and M. W. Chiu, Lingual Hyperpigmentation from Pegylated Interferon and Ribavirin Treatment of Hepatitis C. J Am Acad Dermatol, 2010 ; 62 : 164-5.
DOI
ScienceOn
|
6 |
A. Fernandez, S. Vazquez, and L. Rodriguez- Gonzalez, Tongue Hyperpigmentation Resulting from Peginterferon Alpha-2a and Ribavirin Treatment in a Caucasian Patient with Chronic Hepatitis C. J Eur Acad Dermatol Venereol, 2009 ; 22 : 1389-91.
|
7 |
S. Ghosh, A. Duseja, R. K. Dhiman, and Y. K. Chawla, Tongue Hyperpigmentation Resulting from Peginterferon Alfa-2b and Ribavirin Treatment in a Patient with Chronic Hepatitis C. Dig Dis Sci 2012 ; 57 : 820-1.
DOI
ScienceOn
|
8 |
C. Gurguta, C. Kauer, U. Bergholz et al Tongue and Skin Hyperpigmentation During Peg-Interferon -Alpha/Ribavirin Therapy in Dark-Skinned Non- Caucasian Patients with Chronic Hepatitis C. Am J Gastroenterol, 2006 ; 101 : 197-8.
DOI
ScienceOn
|
9 |
O. Karabay, N. Goksugur, and A. Ogutlu, Tongue Hyperpigmentation During Interferon Therapy, J Dermatol, 2011 ; 38 : 290-1.
DOI
ScienceOn
|
10 |
Y. Radha Krishna, and S. Itha, What Caused This Lingual Hyperpigmentation in a Patient with Chronic Hepatitis C?, Liver Int, 2010 ; 30 : 416.
DOI
ScienceOn
|
11 |
H. A. Torres, L. Bull, R. C. Arduino et al. Tongue Hyperpigmentation in a Caucasian Patient Coinfected with HIV and Hepatitis C During Peginterferon Alfa-2b and Ribavirin Therapy, Am J Gastroenterol, 2007 ; 102 : 1334-5.
DOI
ScienceOn
|